These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 9612241

  • 1. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice.
    Filipsson K, Pacini G, Scheurink AJ, Ahrén B.
    Am J Physiol; 1998 May; 274(5):E834-42. PubMed ID: 9612241
    [Abstract] [Full Text] [Related]

  • 2. The effects of PACAP on insulin secretion and glucose disposal are altered by adrenalectomy in mice.
    Ahrén B, Filipsson K.
    Ann N Y Acad Sci; 2000 May; 921():251-8. PubMed ID: 11193830
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.
    Filipsson K, Tornøe K, Holst J, Ahrén B.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3093-8. PubMed ID: 9284750
    [Abstract] [Full Text] [Related]

  • 4. PACAP contributes to insulin secretion after gastric glucose gavage in mice.
    Filipsson K, Holst JJ, Ahrén B.
    Am J Physiol Regul Integr Comp Physiol; 2000 Aug; 279(2):R424-32. PubMed ID: 10938228
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
    Ahrén B, Hughes TE.
    Endocrinology; 2005 Apr; 146(4):2055-9. PubMed ID: 15604213
    [Abstract] [Full Text] [Related]

  • 6. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.
    Fridolf T, Sundler F, Ahrén B.
    Cell Tissue Res; 1992 Aug; 269(2):275-9. PubMed ID: 1423494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase activating polypeptide enhances glucose-evoked insulin secretion in the canine pancreas in vivo.
    Yamaguchi N.
    JOP; 2001 Sep; 2(5):306-16. PubMed ID: 11877541
    [Abstract] [Full Text] [Related]

  • 9. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
    Sato A, Wang PC, Ohgawara H.
    Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
    [Abstract] [Full Text] [Related]

  • 10. Effect of pituitary adenylate cyclase-activating polypeptide on exocrine and endocrine secretion in the ovine pancreas.
    Onaga T, Uchida M, Kimura M, Miyazaki M, Mineo H, Kato S, Zabielski R.
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):185-93. PubMed ID: 9375356
    [Abstract] [Full Text] [Related]

  • 11. Pituitary adenylate cyclase-activating polypeptide: effects on pancreatic-adrenal hormone secretion and glucose-lipid metabolism in normal conscious dogs.
    Kawai K, Yokota C, Ohashi S, Isobe K, Suzuki S, Nakai T, Yamashita K.
    Metabolism; 1994 Jun; 43(6):739-44. PubMed ID: 8201964
    [Abstract] [Full Text] [Related]

  • 12. Pituitary adenylate cyclase-activating polypeptide (PACAP) and insulin secretion: effects and mechanisms.
    af Klinteberg K, Karlsson S, Moller K, Sundler F, Ahrén B.
    Ann N Y Acad Sci; 1996 Dec 26; 805():543-8. PubMed ID: 8993436
    [No Abstract] [Full Text] [Related]

  • 13. PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion.
    Filipsson K, Sundler F, Ahrén B.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):664-7. PubMed ID: 10080956
    [Abstract] [Full Text] [Related]

  • 14. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
    Ahrén B, Pacini G.
    Am J Physiol; 1999 Dec 24; 277(6):E996-E1004. PubMed ID: 10600787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system.
    Suzuki Y, Kasai K, Takekoshi K, Oka M, Banba N, Numao T, Sugimura H, Iizuka M, Shimoda S.
    Regul Pept; 1993 Sep 03; 47(2):213-20. PubMed ID: 7901874
    [Abstract] [Full Text] [Related]

  • 18. The neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycaemia in mice.
    Persson K, Ahrén B.
    Acta Physiol Scand; 2002 May 03; 175(1):25-8. PubMed ID: 11982501
    [Abstract] [Full Text] [Related]

  • 19. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice.
    Pacini G, Thomaseth K, Ahrén B.
    Am J Physiol Endocrinol Metab; 2001 Oct 03; 281(4):E693-703. PubMed ID: 11551845
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis.
    Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee HW, Eiden LE.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):461-6. PubMed ID: 11756684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.